1 Eli Lilly and Company, Indianapolis, Indiana, United States;
2 RTI Health Solutions, Research Triangle Park, North Carolina, United States;
3 Icahn School of Medicine at Mount Sinai, Ne...
1 Icahn School of Medicine at Mount Sinai, New York, New York, United States;
2 Eli Lilly and Company, Indianapolis, Indiana, United States;
3 University of Oxford, Oxford, United Kingdom...
1 University of Pennsylvania, Pennsylvania, Philadelphia, Pennsylvania, United States;
2 Eli Lilly and Company, Indianapolis, Indiana, United States;
3 Syneos Health, Morrisville, North C...
1 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, United States;
2 Eli Lilly and Company, Indianapolis, Indiana, United States;
3 University of Oxford...
BACKGROUND:
Moderate-to-severe ulcerative colitis (UC) and Crohn’s disease (CD) are associated with substantial quality of life and economic burdens (Kawalec, 2016). The Commu...